Free equity investment tool of Japanese companies

Financial Statement Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

小林製薬

TOWA PHARMACEUTICAL

東京応化工業

Kao

Toray Industries

KANEKA

ONO PHARMACEUTICAL

Aica Kogyo

栄研化学

KUMIAI CHEMICAL INDUSTRY

Noevir Holdings

Hitachi Chemical

キッセイ薬品工業

MANDOM

Nichi-Iko Pharmaceutical

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Nissan Motor

日本アビオニクス

日本アビオニクス

日本アビオニクス

Nittetsu Mining

Financial Statement Details: Nichi-Iko Pharmaceutical (Annual )

Two or more periods are displayed by each of subject collectively.Two or more companies can be compared and financial statement data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Statement data

F/S Outline: Nichi-Iko Pharmaceutical (Annual )

Switch ViewU-ChartU-Chart and F/SF/S

Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
	[BS] 2009-11-30  *  Total: ¥ 57 B  *  Net: ¥ 18 B  (Ratio: 32.73%)	[BS] 2010-11-30  *  Total: ¥ 65 B  *  Net: ¥ 26 B  (Ratio: 39.80%)	[BS] 2011-11-30  *  Total: ¥ 82 B  *  Net: ¥ 44 B  (Ratio: 53.87%)	[BS] 2012-03-31  *  Total: ¥ 88 B  *  Net: ¥ 45 B  (Ratio: 51.47%)	[BS] 2013-03-31  *  Total: ¥ 102 B  *  Net: ¥ 48 B  (Ratio: 47.42%)
Financial Statement Details	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Cash etc.	¥ 1 B	¥ 1 B	¥ 4 B	¥ 6 B	¥ 5 B
Other Current Assets	¥ 32 B	¥ 37 B	¥ 46 B	¥ 47 B	¥ 57 B
Tangible Assets	¥ 17 B	¥ 18 B	¥ 21 B	¥ 23 B	¥ 30 B
Intangible Assets	¥ 3 B	¥ 3 B	¥ 5 B	¥ 5 B	¥ 4 B
Investment etc.	¥ 2 B	¥ 3 B	¥ 6 B	¥ 6 B	¥ 5 B
Total Assets	¥ 57 B	¥ 65 B	¥ 82 B	¥ 88 B	¥ 102 B
Current Liabilities	¥ 29 B	¥ 31 B	¥ 27 B	¥ 29 B	¥ 38 B
Fixed Liabilities	¥ 8 B	¥ 7 B	¥ 11 B	¥ 13 B	¥ 15 B
Capital stock	¥ 3 B	¥ 5 B	¥ 13 B	¥ 13 B	¥ 13 B
Capital surplus etc.	¥ 15 B	¥ 20 B	¥ 31 B	¥ 31 B	¥ 35 B
Liabilities and net assets	¥ 57 B	¥ 65 B	¥ 82 B	¥ 88 B	¥ 102 B
Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Sales Cost of Sales Other income SG&A Other expenses Net income	*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
	[PL] 2009-11-30  *  Sales: ¥ 54 B  *  Income: ¥ 3 B  (Ratio: 6.87%)	[PL] 2010-11-30  *  Sales: ¥ 64 B  *  Income: ¥ 3 B  (Ratio: 6.01%)	[PL] 2011-11-30  *  Sales: ¥ 77 B  *  Income: ¥ 3 B  (Ratio: 5.03%)	[PL] 2012-03-31  *  Sales: ¥ 26 B  *  Income: ¥ 1 B  (Ratio: 4.93%)	[PL] 2013-03-31  *  Sales: ¥ 93 B  *  Income: ¥ 5 B  (Ratio: 5.46%)
Financial Statement Details	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Sales	¥ 54 B	¥ 64 B	¥ 77 B	¥ 26 B	¥ 93 B
Cost of Sales	¥ 30 B	¥ 36 B	¥ 46 B	¥ 16 B	¥ 57 B
Gross profit	¥ 24 B	¥ 27 B	¥ 31 B	¥ 10 B	¥ 36 B
Other income	¥ 466 M	¥ 400 M	¥ 390 M	¥ 267 M	¥ 735 M
SG&A	¥ 18 B	¥ 20 B	¥ 23 B	¥ 7 B	¥ 28 B
Other expenses	¥ 2 B	¥ 3 B	¥ 3 B	¥ 1 B	¥ 3 B
Net income	¥ 3 B	¥ 3 B	¥ 3 B	¥ 1 B	¥ 5 B
Consolidated :Cash flow statement (C/F) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Operating CF Investment CF Financial CF Foreign Exchange Effects Net Change in Cash	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Cash)
	[CF] 2009-11-30  *  OCF: ¥ 7 B  *  Cash: ¥ +478 M	[CF] 2010-11-30  *  OCF: ¥ 2 B  *  Cash: ¥ +163 M	[CF] 2011-11-30  *  OCF: ¥ 1 B  *  Cash: ¥ +2 B	[CF] 2012-03-31  *  OCF: ¥ 3 B  *  Cash: ¥ +1 B	[CF] 2013-03-31  *  OCF: ¥ 9 B  *  Cash: ¥ -715 M
Financial Statement Details	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Operating CF	¥ 7 B	¥ 2 B	¥ 1 B	¥ 3 B	¥ 9 B
Investment CF	¥ -6 B	¥ -5 B	¥ -9 B	¥ -1 B	¥ -7 B
Financial CF	¥ -302 M	¥ 2 B	¥ 10 B	¥ -126 M	¥ -3 B
Foreign Exchange Effects	¥ -31 K	¥ -9 K	¥ -18 K	¥ 14 K	¥ 1 M
Net Change in Cash	¥ 478 M	¥ 163 M	¥ 2 B	¥ 1 B	¥ -715 M
Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
	[SS] 2009-11-30  *  Income: ¥ 3 B  *  Net: ¥ +2 B	[SS] 2010-11-30  *  Income: ¥ 3 B  *  Net: ¥ +7 B	[SS] 2011-11-30  *  Income: ¥ 3 B  *  Net: ¥ +18 B	[SS] 2012-03-31  *  Income: ¥ 1 B  *  Net: ¥ +935 M	[SS] 2013-03-31  *  Income: ¥ 5 B  *  Net: ¥ +3 B
Financial Statement Details	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Issuance of new shares	-	¥ 4 B	¥ 16 B	-	-
Dividends from surplus	¥ -864 M	¥ -925 M	¥ -1 B	¥ -640 M	¥ -1 B
Net income	¥ 3 B	¥ 3 B	¥ 3 B	¥ 1 B	¥ 5 B
Purchase of treasury stock	¥ -167 M	¥ 38 M	¥ -804 M	¥ 75 M	¥ -834 M
Other Change in Stockholders Equity	¥ 728 K	¥ 2 M	¥ -1 K	-	¥ -12 M
Other Change in Net Assets	¥ -1 M	¥ -102 M	¥ 12 M	¥ 170 M	¥ 60 M
Net Change in Net Assets	¥ 2 B	¥ 7 B	¥ 18 B	¥ 935 M	¥ 3 B

Non-Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
	[BS] 2009-11-30  *  Total: ¥ 51 B  *  Net: ¥ 16 B  (Ratio: 31.78%)	[BS] 2010-11-30  *  Total: ¥ 59 B  *  Net: ¥ 22 B  (Ratio: 38.28%)	[BS] 2011-11-30  *  Total: ¥ 76 B  *  Net: ¥ 40 B  (Ratio: 52.76%)	[BS] 2012-03-31  *  Total: ¥ 79 B  *  Net: ¥ 41 B  (Ratio: 51.96%)	[BS] 2013-03-31  *  Total: ¥ 99 B  *  Net: ¥ 48 B  (Ratio: 49.05%)
Financial Statement Details	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Cash etc.	¥ 1 B	¥ 986 M	¥ 3 B	¥ 5 B	-
Other Current Assets	¥ 29 B	¥ 34 B	¥ 43 B	¥ 45 B	-
Tangible Assets	¥ 11 B	¥ 12 B	¥ 15 B	¥ 14 B	-
Intangible Assets	¥ 2 B	¥ 2 B	¥ 4 B	¥ 3 B	-
Investment etc.	¥ 7 B	¥ 8 B	¥ 10 B	¥ 9 B	¥ 99 B
Total Assets	¥ 51 B	¥ 59 B	¥ 76 B	¥ 79 B	¥ 99 B
Current Liabilities	¥ 28 B	¥ 30 B	¥ 26 B	¥ 27 B	¥ 50 B
Fixed Liabilities	¥ 6 B	¥ 6 B	¥ 9 B	¥ 10 B	-
Capital stock	¥ 3 B	¥ 5 B	¥ 13 B	¥ 13 B	-
Capital surplus etc.	¥ 13 B	¥ 17 B	¥ 26 B	¥ 27 B	¥ 48 B
Liabilities and net assets	¥ 51 B	¥ 59 B	¥ 76 B	¥ 79 B	¥ 99 B
Non-Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Sales Cost of Sales Other income SG&A Other expenses Net income	*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
	[PL] 2009-11-30  *  Sales: ¥ 52 B  *  Income: ¥ 2 B  (Ratio: 5.35%)	[PL] 2010-11-30  *  Sales: ¥ 62 B  *  Income: ¥ 2 B  (Ratio: 4.50%)	[PL] 2011-11-30  *  Sales: ¥ 76 B  *  Income: ¥ 3 B  (Ratio: 4.14%)	[PL] 2012-03-31  *  Sales: ¥ 26 B  *  Income: ¥ 1 B  (Ratio: 4.45%)	[PL] 2013-03-31  *  Sales: ¥ 93 B  *  Income: ¥ 9 B  (Ratio: 10.11%)
Financial Statement Details	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Sales	¥ 52 B	¥ 62 B	¥ 76 B	¥ 26 B	¥ 93 B
Cost of Sales	¥ 30 B	¥ 37 B	¥ 48 B	¥ 17 B	¥ 83 B
Gross profit	¥ 22 B	¥ 25 B	¥ 28 B	¥ 9 B	¥ 9 B
Other income	¥ 237 M	¥ 277 M	¥ 285 M	¥ 252 M	-
SG&A	¥ 17 B	¥ 19 B	¥ 22 B	¥ 7 B	-
Other expenses	¥ 2 B	¥ 3 B	¥ 3 B	¥ 1 B	-
Net income	¥ 2 B	¥ 2 B	¥ 3 B	¥ 1 B	¥ 9 B
Non-Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-11-30	2010-11-30	2011-11-30	2012-03-31
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
	[SS] 2009-11-30  *  Income: ¥ 2 B  *  Net: ¥ +1 B	[SS] 2010-11-30  *  Income: ¥ 2 B  *  Net: ¥ +6 B	[SS] 2011-11-30  *  Income: ¥ 3 B  *  Net: ¥ +17 B	[SS] 2012-03-31  *  Income: -  *  Net: -
Financial Statement Details	2009-11-30	2010-11-30	2011-11-30	2012-03-31
Issuance of new shares	-	¥ 4 B	¥ 16 B	-
Dividends from surplus	¥ -864 M	¥ -925 M	¥ -1 B	-
Net income	¥ 2 B	¥ 2 B	¥ 3 B	-
Purchase of treasury stock	¥ -167 M	¥ 38 M	¥ -804 M	-
Other Change in Stockholders Equity	¥ 729 K	¥ 2 M	-	¥ 1 K
Other Change in Net Assets	¥ -13 M	¥ -79 M	¥ 10 M	-
Net Change in Net Assets	¥ 1 B	¥ 6 B	¥ 17 B	-

---

Consolidated :Balance sheet (BS) Consolidated | Non-Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Balance sheet (Annual )	2008-11-30	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Net assets	¥ 16 B	¥ 18 B	¥ 26 B	¥ 44 B	¥ 45 B	¥ 48 B
Cash and deposits	¥ 1 B	¥ 1 B	¥ 1 B	¥ 4 B	¥ 6 B	¥ 5 B
Notes and accounts receivable-trade	¥ 17 B	¥ 14 B	¥ 18 B	¥ 24 B	¥ 23 B	¥ 26 B
Short-term investment securities	¥ 666 K	¥ 1 M	¥ 666 K	¥ 1 M	¥ 1 M	-
Merchandise and finished goods		¥ 9 B	¥ 10 B	¥ 13 B	¥ 14 B	¥ 18 B
Raw materials and supplies		¥ 3 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 5 B
Work in process		¥ 2 B	¥ 3 B	¥ 2 B	¥ 3 B	¥ 4 B
Deferred tax assets	¥ 557 M	¥ 972 M	¥ 935 M	¥ 1 B	¥ 698 M	¥ 876 M
Allowance for doubtful accounts	¥ -415 M	¥ -421 M	¥ -416 M	¥ -443 M	¥ -463 M	¥ -71 M
Other	¥ 1 B	¥ 1 B	¥ 1 B	¥ 856 M	¥ 990 M	¥ 1 B
Current assets	¥ 32 B	¥ 33 B	¥ 39 B	¥ 50 B	¥ 53 B	¥ 62 B
Buildings and structures, net	¥ 5 B	¥ 4 B	¥ 9 B	¥ 11 B	¥ 12 B	¥ 15 B
Tools, furniture and fixtures, net	¥ 341 M	¥ 311 M	¥ 272 M	¥ 980 M	¥ 899 M	¥ 663 M
Machinery, equipment and vehicles, net	¥ 2 B	¥ 1 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 7 B
Land	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 4 B	¥ 4 B
Lease assets, net		¥ 498 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
Construction in progress	¥ 1 B	¥ 6 B	¥ 976 M	¥ 122 M	¥ 1 B	¥ 438 M
Property, plant and equipment	¥ 13 B	¥ 17 B	¥ 18 B	¥ 21 B	¥ 23 B	¥ 30 B
Goodwill	¥ 963 M	¥ 1 B	¥ 938 M	¥ 804 M	¥ 1 B	¥ 1 B
Lease assets		¥ 191 M	¥ 385 M	¥ 424 M	¥ 384 M	¥ 556 M
Other	¥ 1 B	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 2 B
Intangible assets	¥ 2 B	¥ 3 B	¥ 3 B	¥ 5 B	¥ 5 B	¥ 4 B
Investment securities	¥ 1 B	¥ 1 B	¥ 2 B	¥ 4 B	¥ 4 B	¥ 4 B
Long-term loans receivable	¥ 78 M	¥ 74 M	¥ 326 M	¥ 698 M	¥ 755 M	¥ 735 M
Deferred tax assets	¥ 758 M	¥ 768 M	¥ 604 M	¥ 877 M	¥ 705 M	¥ 529 M
Other	¥ 363 M	¥ 354 M	¥ 308 M	¥ 460 M	¥ 448 M	¥ 572 M
Allowance for doubtful accounts	¥ -81 M	¥ -76 M	¥ -78 M	¥ -145 M	¥ -144 M	¥ -264 M
Investments and other assets	¥ 2 B	¥ 2 B	¥ 3 B	¥ 6 B	¥ 6 B	¥ 5 B
Noncurrent assets	¥ 18 B	¥ 23 B	¥ 25 B	¥ 32 B	¥ 34 B	¥ 40 B
Assets	¥ 50 B	¥ 57 B	¥ 65 B	¥ 82 B	¥ 88 B	¥ 102 B
Notes and accounts payable-trade	¥ 10 B	¥ 11 B	¥ 13 B	¥ 13 B	¥ 16 B	¥ 22 B
Accrued expenses	¥ 957 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 449 M	¥ 634 M
Lease obligations		¥ 151 M	¥ 365 M	¥ 495 M	¥ 558 M	¥ 953 M
Provision for bonuses				-	¥ 477 M	¥ 536 M
Provision for sales returns	¥ 56 M	¥ 39 M	¥ 48 M	¥ 60 M	¥ 57 M	¥ 77 M
Accounts payable-other	¥ 1 B	¥ 2 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 4 B
Income taxes payable	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B	¥ 534 M	¥ 2 B
Deposits received	¥ 127 M	¥ 82 M	¥ 82 M	¥ 86 M	¥ 147 M	¥ 157 M
Short-term loans payable	¥ 13 B	¥ 11 B	¥ 12 B	¥ 5 B	¥ 5 B	¥ 4 B
Current portion of long-term loans payable	¥ 892 M	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B
Other	¥ 58 M	¥ 91 M	¥ 70 M	¥ 97 M	¥ 132 M	¥ 143 M
Current liabilities	¥ 28 B	¥ 29 B	¥ 31 B	¥ 27 B	¥ 29 B	¥ 38 B
Long-term loans payable	¥ 2 B	¥ 4 B	¥ 3 B	¥ 6 B	¥ 8 B	¥ 9 B
Provision for retirement benefits	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 3 B
Lease obligations		¥ 580 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
Asset retirement obligations				¥ 50 M	¥ 54 M	¥ 55 M
Deferred tax liabilities	¥ 663 M	¥ 582 M	¥ 322 M	¥ 415 M	¥ 357 M	¥ 11 M
Deferred tax liabilities for land revaluation	¥ 293 M	¥ 292 M	¥ 291 M	¥ 291 M	¥ 255 M	¥ 255 M
Other	¥ 60 M	¥ 6 M	¥ 4 M	¥ 19 M	¥ 19 M	¥ 9 M
Noncurrent liabilities	¥ 6 B	¥ 8 B	¥ 7 B	¥ 11 B	¥ 13 B	¥ 15 B
Liabilities	¥ 34 B	¥ 38 B	¥ 39 B	¥ 38 B	¥ 42 B	¥ 54 B
Capital stock	¥ 3 B	¥ 3 B	¥ 5 B	¥ 13 B	¥ 13 B	¥ 13 B
Capital surplus	¥ 1 B	¥ 1 B	¥ 4 B	¥ 12 B	¥ 12 B	¥ 12 B
Retained earnings	¥ 11 B	¥ 14 B	¥ 16 B	¥ 19 B	¥ 20 B	¥ 24 B
Treasury stock	¥ -255 M	¥ -423 M	¥ -392 M	¥ -1 B	¥ -1 B	¥ -1 B
Shareholders' equity	¥ 15 B	¥ 18 B	¥ 25 B	¥ 44 B	¥ 45 B	¥ 48 B
Valuation difference on available-for-sale securities	¥ 49 M	¥ 49 M	¥ -51 M	¥ -38 M	¥ 95 M	¥ 113 M
Revaluation reserve for land	¥ 264 M	¥ 263 M	¥ 261 M	¥ 261 M	¥ 297 M	¥ 297 M
Valuation and translation adjustments	¥ 314 M	¥ 313 M	¥ 210 M	¥ 222 M	¥ 393 M	¥ 411 M
Subscription rights to shares					-	¥ 42 M
Liabilities and net assets	¥ 50 B	¥ 57 B	¥ 65 B	¥ 82 B	¥ 88 B	¥ 102 B
Inventories	¥ 13 B
Provision for directors' bonuses	¥ 27 M
Minority interests
Consolidated :Income statement (PL) Consolidated | Non-Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Income statement (Annual )	2008-11-30	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Net sales	¥ 42 B	¥ 54 B	¥ 64 B	¥ 77 B	¥ 26 B	¥ 93 B
Operating income	¥ 5 B	¥ 6 B	¥ 7 B	¥ 7 B	¥ 2 B	¥ 8 B
Ordinary income	¥ 5 B	¥ 6 B	¥ 6 B	¥ 7 B	¥ 2 B	¥ 8 B
Net income	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 1 B	¥ 5 B
Comprehensive income				¥ 3 B	¥ 1 B	¥ 5 B
Cost of sales	¥ 22 B	¥ 30 B	¥ 36 B	¥ 46 B	¥ 16 B	¥ 57 B
Selling, general and administrative expenses	¥ 14 B	¥ 18 B	¥ 20 B	¥ 23 B	¥ 7 B	¥ 28 B
Gross profit	¥ 20 B	¥ 24 B	¥ 27 B	¥ 31 B	¥ 10 B	¥ 36 B
Gross profit-net	¥ 20 B	¥ 24 B	¥ 27 B	¥ 31 B	¥ 10 B	¥ 36 B
Provision for sales returns			¥ 9 M	¥ 12 M	-	¥ 20 M
Reversal of provision for sales returns	¥ 8 M	¥ 17 M		-	¥ 3 M	-
Interest income	¥ 3 M	¥ 3 M	¥ 5 M	¥ 13 M	¥ 4 M	¥ 18 M
Dividends income	¥ 12 M	¥ 15 M	¥ 16 M	¥ 23 M	¥ 62 M	¥ 83 M
Amortization of negative goodwill	¥ 229 M	¥ 229 M	¥ 124 M	¥ 18 M	¥ 6 M	¥ 3 M
Foreign exchange gains					¥ 16 M	¥ 61 M
Compensation income				¥ 71 M	¥ 44 M	¥ 18 M
Other	¥ 51 M	¥ 107 M	¥ 186 M	¥ 134 M	¥ 92 M	¥ 213 M
Non-operating income	¥ 598 M	¥ 460 M	¥ 385 M	¥ 361 M	¥ 267 M	¥ 575 M
Interest expenses	¥ 194 M	¥ 268 M	¥ 231 M	¥ 188 M	¥ 48 M	¥ 155 M
Commission fee		¥ 86 M	¥ 121 M	¥ 34 M	¥ 14 M	¥ 32 M
Loss on sales of accounts receivable			¥ 76 M	¥ 86 M	¥ 30 M	¥ 99 M
Other	¥ 55 M	¥ 146 M	¥ 55 M	¥ 133 M	¥ 13 M	¥ 46 M
Non-operating expenses	¥ 331 M	¥ 584 M	¥ 599 M	¥ 543 M	¥ 106 M	¥ 334 M
Gain on sales of noncurrent assets	¥ 7 M	¥ 6 M	¥ 11 M	¥ 3 M	-	¥ 271 K
Gain on sales of investment securities					-	¥ 160 M
Extraordinary income	¥ 29 M	¥ 6 M	¥ 14 M	¥ 29 M	-	¥ 160 M
Loss on disposal of noncurrent assets	¥ 142 M	¥ 32 M	¥ 88 M	¥ 132 M	¥ 2 M	¥ 98 M
Other	¥ 18 M	¥ 62 M	¥ 13 M	¥ 55 M	-	¥ 655 K
Extraordinary loss	¥ 465 M	¥ 662 M	¥ 1 B	¥ 753 M	¥ 2 M	¥ 461 M
Income before income taxes	¥ 5 B	¥ 5 B	¥ 5 B	¥ 6 B	¥ 2 B	¥ 8 B
Income taxes	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 967 M	¥ 3 B
Income taxes-current	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 509 M	¥ 3 B
Income taxes-deferred	¥ -632 M	¥ -498 M	¥ -24 M	¥ -297 M	¥ 458 M	¥ -313 M
Income before minority interests				¥ 3 B	¥ 1 B	¥ 5 B
Valuation difference on available-for-sale securities				¥ 12 M	¥ 134 M	¥ 17 M
Other comprehensive income				¥ 12 M	¥ 170 M	¥ 17 M
Comprehensive income attributable to owners of the parent				¥ 3 B	¥ 1 B	¥ 5 B
Comprehensive income attributable to minority interests					-	-
Stock issuance cost				¥ 100 M	-
Gain on revision of retirement benefit plan				¥ 25 M	-
Loss on disaster				¥ 233 M	-
Loss on valuation of investment securities	¥ 94 M	¥ 140 M	¥ 48 M	¥ 101 M	-
Loss on sales of notes payable	¥ 81 M	¥ 82 M	¥ 33 M
Reversal of allowance for doubtful accounts			¥ 3 M
Impairment loss	¥ 83 M	¥ 1 M	¥ 378 M
Other	¥ 4 M	¥ 374 K
Loss on valuation of inventories		¥ 384 M
Gain on liquidation of subsidiaries and affiliates	¥ 17 M
Minority interests in income	¥ 3 M
Consolidated :Cash flow statement (CF) Consolidated | Non-Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Cash flow statement (Annual )	2008-11-30	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Subtotal	¥ 1 B	¥ 9 B	¥ 5 B	¥ 3 B	¥ 5 B	¥ 11 B
Depreciation and amortization	¥ 1 B	¥ 1 B	¥ 2 B	¥ 4 B	¥ 1 B	¥ 4 B
Amortization of goodwill	¥ 107 M	¥ 189 M	¥ 189 M	¥ 153 M	¥ 47 M	¥ 179 M
Increase (decrease) in allowance for doubtful accounts	¥ 159 M	¥ 544 K	¥ -2 M	¥ 94 M	¥ 13 M	¥ -274 M
Interest and dividends income	¥ -15 M	¥ -18 M	¥ -22 M	¥ -37 M	¥ -66 M	¥ -101 M
Interest expenses	¥ 194 M	¥ 268 M	¥ 231 M	¥ 188 M	¥ 48 M	¥ 155 M
Decrease (increase) in notes and accounts receivable-trade	¥ -1 B	¥ 2 B	¥ -4 B	¥ -6 B	¥ 1 B	¥ -2 B
Decrease (increase) in inventories	¥ -3 B	¥ -2 B	¥ -1 B	¥ -2 B	¥ -1 B	¥ -5 B
Increase (decrease) in notes and accounts payable-trade	¥ 930 M	¥ 1 B	¥ 1 B	¥ 98 M	¥ 2 B	¥ 6 B
Loss (gain) on sales of investment securities					-	¥ -160 M
Amortization of negative goodwill	¥ -229 M	¥ -229 M	¥ -124 M	¥ -18 M	¥ -6 M	¥ -3 M
Increase (decrease) in provision for bonuses				-	¥ 467 M	¥ 53 M
Increase (decrease) in provision for retirement benefits	¥ -146 M	¥ 61 M	¥ 86 M	¥ 122 M	¥ 68 M	¥ 230 M
Increase (decrease) in provision for sales returns	¥ -8 M	¥ -17 M	¥ 9 M	¥ 12 M	¥ -3 M	¥ 20 M
Loss (gain) on valuation of investment securities	¥ 94 M	¥ 140 M	¥ 48 M	¥ 101 M	-	¥ 280 K
Loss (gain) on sales of noncurrent assets	¥ -7 M	¥ -6 M	¥ -11 M	¥ -3 M	-	¥ -271 K
Loss (gain) on disposal of noncurrent assets	¥ 142 M	¥ 32 M	¥ 88 M	¥ 132 M	¥ 2 M	¥ 98 M
Increase (decrease) in accrued expenses				¥ 55 M	¥ -685 M	¥ 159 M
Other, net	¥ -510 M	¥ 789 M	¥ -155 M	¥ 549 M	¥ 411 M	¥ 292 M
Interest and dividends income received	¥ 14 M	¥ 19 M	¥ 22 M	¥ 32 M	¥ 17 M	¥ 101 M
Interest expenses paid	¥ -192 M	¥ -245 M	¥ -259 M	¥ -176 M	¥ -43 M	¥ -154 M
Income taxes paid	¥ -721 M	¥ -2 B	¥ -2 B	¥ -2 B	¥ -1 B	¥ -1 B
Net cash provided by (used in) operating activities	¥ 483 M	¥ 7 B	¥ 2 B	¥ 1 B	¥ 3 B	¥ 9 B
Proceeds from sales of short-term investment securities	¥ 666 K	¥ 666 K	¥ 666 K	¥ 666 K	¥ 666 K	¥ 666 K
Purchase of property, plant and equipment	¥ -2 B	¥ -5 B	¥ -3 B	¥ -4 B	¥ -1 B	¥ -7 B
Proceeds from sales of property, plant and equipment	¥ 240 M	¥ 11 M	¥ 25 M	¥ 15 M	¥ 410 K	¥ 9 M
Purchase of investment securities	¥ -55 M	¥ -241 M	¥ -66 M	¥ -118 M	¥ -2 M	¥ -33 M
Proceeds from sales of investment securities					-	¥ 88 M
Payments of loans receivable	¥ -2 M	¥ -254 M	¥ -20 M	¥ -434 M	¥ -100 M	-
Collection of loans receivable	¥ 2 M	¥ 797 K	¥ 698 K	¥ 24 M	¥ 1 M	¥ 4 M
Purchase of intangible assets	¥ -1 B	¥ -475 M	¥ -1 B	¥ -2 B	-	¥ -16 M
Payments into time deposits	¥ -48 M	¥ -15 M		¥ -1 B	-	¥ -57 M
Proceeds from withdrawal of time deposits	¥ 48 M	¥ 18 M	¥ 15 M	¥ 1 B	-	¥ 332 M
Purchase of stocks of subsidiaries and affiliates	¥ -107 M	¥ -232 M	¥ -1 B	¥ -1 B	¥ -3 M	¥ -7 M
Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation				-	¥ 113 M	¥ 40 M
Other, net	¥ -36 M	¥ -32 M	¥ 4 M	¥ -21 M	¥ 2 M	¥ -130 M
Net cash provided by (used in) investing activities	¥ -4 B	¥ -6 B	¥ -5 B	¥ -9 B	¥ -1 B	¥ -7 B
Proceeds from long-term loans payable	¥ 2 B	¥ 4 B		¥ 6 B	¥ 1 B	¥ 6 B
Repayment of long-term loans payable	¥ -1 B	¥ -2 B	¥ -1 B	¥ -2 B	¥ -849 M	¥ -4 B
Purchase of treasury stock	¥ -9 M	¥ -188 M	¥ -1 M	¥ -861 M	¥ -250 K	¥ -991 M
Cash dividends paid	¥ -885 M	¥ -863 M	¥ -923 M	¥ -1 B	¥ -633 M	¥ -1 B
Net increase (decrease) in short-term loans payable	¥ 4 B	¥ -1 B	¥ 1 B	¥ -7 B	¥ -457 M	¥ -1 B
Repayments of finance lease obligations		¥ -21 M	¥ -230 M	¥ -428 M	¥ -161 M	¥ -724 M
Proceeds from sales of treasury stock	¥ 1 M	¥ 304 K		¥ 30 M	¥ 75 M	¥ 156 M
Net cash provided by (used in) financing activities	¥ 4 B	¥ -302 M	¥ 2 B	¥ 10 B	¥ -126 M	¥ -3 B
Effect of exchange rate change on cash and cash equivalents	¥ -52 K	¥ -31 K	¥ -9 K	¥ -18 K	¥ 14 K	¥ 1 M
Net increase (decrease) in cash and cash equivalents	¥ 255 M	¥ 478 M	¥ 163 M	¥ 2 B	¥ 1 B	¥ -715 M
Cash and cash equivalents	¥ 544 M	¥ 1 B	¥ 1 B	¥ 3 B	¥ 5 B	¥ 4 B
Stock issuance cost				¥ 100 M	-
Proceeds from issuance of common stock			¥ 4 B	¥ 16 B	-
Proceeds from exercise of stock option	¥ 177 M	¥ 20 M	¥ 40 M	¥ 26 M	-
Impairment loss	¥ 83 M	¥ 1 M	¥ 378 M
Increase (decrease) in provision for directors' bonuses		¥ -27 M
Proceeds from sales of intangible assets	¥ 1 B	¥ 158 M
Purchase of investments in subsidiaries resulting in change in scope of consolidation	¥ -2 B
Consolidated :Shareowners' equity (SS) Consolidated | Non-Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Shareowners' equity (Annual )	2008-11-30	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Total changes of items during the period			¥ 2 B	¥ 8 B	-	-
Disposal of treasury stock	¥ 19 M	¥ 644 K	¥ 7 M	¥ 806 K	¥ -18 M	¥ -47 M
Total changes of items during the period	¥ 148 M	¥ 644 K	¥ 2 B	¥ 8 B	¥ -18 M	¥ -47 M
Dividends from surplus	¥ -890 M	¥ -864 M	¥ -925 M	¥ -1 B	¥ -640 M	¥ -1 B
Total changes of items during the period	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 689 M	¥ 4 B
Purchase of treasury stock	¥ -9 M	¥ -188 M	¥ -1 M	¥ -861 M	¥ -250 K	¥ -991 M
Disposal of treasury stock	¥ 159 M	¥ 20 M	¥ 33 M	¥ 55 M	¥ 93 M	¥ 203 M
Total changes of items during the period	¥ 213 M	¥ -168 M	¥ 31 M	¥ -805 M	¥ 93 M	¥ -799 M
Dividends from surplus	¥ -890 M	¥ -864 M	¥ -925 M	¥ -1 B	¥ -640 M	¥ -1 B
Net income	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 1 B	¥ 5 B
Purchase of treasury stock	¥ -9 M	¥ -188 M	¥ -1 M	¥ -861 M	¥ -250 K	¥ -991 M
Disposal of treasury stock	¥ 178 M	¥ 20 M	¥ 40 M	¥ 56 M	¥ 75 M	¥ 156 M
Total changes of items during the period	¥ 2 B	¥ 2 B	¥ 7 B	¥ 18 B	¥ 765 M	¥ 3 B
Net changes of items other than shareholders' equity	¥ -191 M	¥ -691 K	¥ -100 M	¥ 12 M	¥ 134 M	¥ 17 M
Total changes of items during the period	¥ -191 M	¥ -691 K	¥ -100 M	¥ 12 M	¥ 134 M	¥ 17 M
Net changes of items other than shareholders' equity	¥ 732 M	¥ -729 K	¥ -2 M		¥ 36 M	¥ 26 K
Total changes of items during the period	¥ 732 M	¥ -729 K	¥ -2 M		¥ 36 M	¥ 26 K
Net changes of items other than shareholders' equity	¥ 540 M	¥ -1 M	¥ -102 M	¥ 12 M	¥ 170 M	¥ 17 M
Total changes of items during the period	¥ 540 M	¥ -1 M	¥ -102 M	¥ 12 M	¥ 170 M	¥ 17 M
Net changes of items other than shareholders' equity					-	¥ 42 M
Total changes of items during the period					-	¥ 42 M
Dividends from surplus	¥ -890 M	¥ -864 M	¥ -925 M	¥ -1 B	¥ -640 M	¥ -1 B
Net income	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 1 B	¥ 5 B
Purchase of treasury stock	¥ -9 M	¥ -188 M	¥ -1 M	¥ -861 M	¥ -250 K	¥ -991 M
Disposal of treasury stock	¥ 178 M	¥ 20 M	¥ 40 M	¥ 56 M	¥ 75 M	¥ 156 M
Net changes of items other than shareholders' equity	¥ 459 M	¥ -1 M	¥ -102 M	¥ 12 M	¥ 170 M	¥ 60 M
Total changes of items during the period	¥ 2 B	¥ 2 B	¥ 7 B	¥ 18 B	¥ 935 M	¥ 3 B
Issuance of new shares			¥ 2 B	¥ 8 B	-
Issuance of new shares			¥ 2 B	¥ 8 B	-
Issuance of new shares			¥ 4 B	¥ 16 B	-
Issuance of new shares			¥ 4 B	¥ 16 B	-
Reversal of revaluation reserve for land	¥ -732 M	¥ 729 K	¥ 2 M
Reversal of revaluation reserve for land	¥ -732 M	¥ 729 K	¥ 2 M
Reversal of revaluation reserve for land	¥ -732 M	¥ 729 K	¥ 2 M
Increase by share exchanges	¥ 129 M
Increase by share exchanges	¥ 193 M
Net changes of items other than shareholders' equity	¥ -81 M
Total changes of items during the period	¥ -81 M
Increase by share exchanges	¥ 193 M

Non-Consolidated :Balance sheet (BS) Consolidated | Non-Consolidated Balance sheet | Income statement | Shareowners' equity
Non-Consolidated :Balance sheet (Annual )	2008-11-30	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Net assets	¥ 14 B	¥ 16 B	¥ 22 B	¥ 40 B	¥ 41 B
Cash and deposits	¥ 583 M	¥ 1 B	¥ 986 M	¥ 3 B	¥ 5 B
Notes receivable-trade	¥ 1 B	¥ 2 B	¥ 3 B	¥ 5 B	¥ 5 B
Accounts receivable-trade	¥ 15 B	¥ 11 B	¥ 15 B	¥ 18 B	¥ 18 B
Short-term investment securities	¥ 666 K	¥ 1 M	¥ 666 K	¥ 1 M	¥ 1 M
Merchandise and finished goods		¥ 8 B	¥ 8 B	¥ 11 B	¥ 12 B
Raw materials and supplies		¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B
Work in process	¥ 913 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Prepaid expenses	¥ 192 M	¥ 341 M	¥ 222 M	¥ 169 M	¥ 184 M
Deferred tax assets	¥ 354 M	¥ 612 M	¥ 692 M	¥ 799 M	¥ 478 M
Short-term loans receivable	¥ 417 M	¥ 453 M	¥ 502 M	¥ 486 M	¥ 704 M
Short-term loans receivable from subsidiaries and affiliates		¥ 254 M		-	¥ 1 B
Accounts receivable-other	¥ 312 M	¥ 374 M	¥ 1 B	¥ 1 B	¥ 1 B
Current portion of long-term loans receivable from subsidiaries and affiliates		¥ 400 M	¥ 400 M	¥ 385 M	¥ 515 M
Allowance for doubtful accounts	¥ -415 M	¥ -421 M	¥ -416 M	¥ -443 M	¥ -460 M
Other	¥ 126 M	¥ 5 M	¥ 12 M	¥ 14 M	¥ 15 M
Current assets	¥ 29 B	¥ 30 B	¥ 35 B	¥ 47 B	¥ 50 B
Buildings, net	¥ 2 B	¥ 2 B	¥ 5 B	¥ 7 B	¥ 7 B
Structures, net	¥ 76 M	¥ 64 M	¥ 636 M	¥ 740 M	¥ 732 M
Machinery and equipment, net	¥ 512 M	¥ 386 M	¥ 2 B	¥ 2 B	¥ 2 B
Vehicles, net	¥ 829 K	¥ 954 K	¥ 2 M	¥ 896 K	¥ 703 K
Tools, furniture and fixtures, net	¥ 211 M	¥ 193 M	¥ 202 M	¥ 755 M	¥ 671 M
Land	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B
Lease assets, net		¥ 498 M	¥ 1 B	¥ 1 B	¥ 1 B
Construction in progress	¥ 1 B	¥ 6 B	¥ 380 M	¥ 119 M	¥ 3 M
Property, plant and equipment	¥ 6 B	¥ 11 B	¥ 12 B	¥ 15 B	¥ 14 B
Software	¥ 9 M	¥ 6 M	¥ 7 M	¥ 5 M	¥ 4 M
Lease assets		¥ 155 M	¥ 357 M	¥ 403 M	¥ 365 M
Telephone subscription right	¥ 14 M	¥ 14 M	¥ 14 M	¥ 14 M	¥ 14 M
Intangible assets	¥ 1 B	¥ 2 B	¥ 2 B	¥ 4 B	¥ 3 B
Investment securities	¥ 846 M	¥ 979 M	¥ 895 M	¥ 927 M	¥ 1 B
Stocks of subsidiaries and affiliates	¥ 4 B	¥ 4 B	¥ 5 B	¥ 7 B	¥ 7 B
Investments in capital	¥ 11 K	¥ 11 K	¥ 11 K	¥ 11 K	¥ 11 K
Long-term loans receivable	¥ 78 M	¥ 74 M	¥ 71 M	¥ 444 M	¥ 501 M
Long-term loans receivable from subsidiaries and affiliates	¥ 2 B	¥ 1 B	¥ 1 B	¥ 484 M	¥ 254 M
Claims provable in bankruptcy, claims provable in rehabilitation and other	¥ 2 M	¥ 8 M	¥ 6 M	¥ 93 M	¥ 85 M
Long-term prepaid expenses	¥ 51 M	¥ 53 M	¥ 19 M	¥ 59 M	¥ 51 M
Deferred tax assets	¥ 757 M	¥ 768 M	¥ 604 M	¥ 877 M	¥ 705 M
Other	¥ 246 M	¥ 278 M	¥ 271 M	¥ 294 M	¥ 289 M
Allowance for doubtful accounts	¥ -81 M	¥ -76 M	¥ -77 M	¥ -144 M	¥ -143 M
Investments and other assets	¥ 8 B	¥ 7 B	¥ 8 B	¥ 10 B	¥ 9 B
Noncurrent assets	¥ 16 B	¥ 21 B	¥ 23 B	¥ 29 B	¥ 28 B
Assets	¥ 45 B	¥ 51 B	¥ 59 B	¥ 76 B	¥ 79 B
Notes payable-trade	¥ 6 B	¥ 6 B	¥ 5 B	¥ 5 B	¥ 6 B
Accounts payable-trade	¥ 5 B	¥ 6 B	¥ 9 B	¥ 10 B	¥ 11 B
Accrued expenses	¥ 820 M	¥ 851 M	¥ 789 M	¥ 849 M	¥ 301 M
Lease obligations		¥ 144 M	¥ 342 M	¥ 469 M	¥ 503 M
Provision for bonuses				-	¥ 358 M
Provision for sales returns	¥ 56 M	¥ 39 M	¥ 48 M	¥ 60 M	¥ 57 M
Accounts payable-other	¥ 849 M	¥ 2 B	¥ 1 B	¥ 1 B	¥ 2 B
Income taxes payable	¥ 1 B	¥ 1 B	¥ 776 M	¥ 1 B	¥ 433 M
Deposits received	¥ 105 M	¥ 72 M	¥ 74 M	¥ 78 M	¥ 134 M
Short-term loans payable	¥ 11 B	¥ 9 B	¥ 10 B	¥ 3 B	¥ 3 B
Current portion of long-term loans payable	¥ 400 M	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B
Other	¥ 164 M	¥ 51 M	¥ 474 M	¥ 70 M	¥ 143 M
Current liabilities	¥ 26 B	¥ 28 B	¥ 30 B	¥ 26 B	¥ 27 B
Long-term loans payable	¥ 1 B	¥ 4 B	¥ 2 B	¥ 5 B	¥ 6 B
Provision for retirement benefits	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B
Lease obligations		¥ 550 M	¥ 1 B	¥ 1 B	¥ 1 B
Asset retirement obligations				¥ 4 M	¥ 4 M
Deferred tax liabilities for land revaluation	¥ 293 M	¥ 292 M	¥ 291 M	¥ 291 M	¥ 255 M
Other	¥ 7 M	¥ 6 M	¥ 4 M	¥ 19 M	¥ 19 M
Noncurrent liabilities	¥ 3 B	¥ 6 B	¥ 6 B	¥ 9 B	¥ 10 B
Liabilities	¥ 30 B	¥ 35 B	¥ 36 B	¥ 36 B	¥ 38 B
Capital stock	¥ 3 B	¥ 3 B	¥ 5 B	¥ 13 B	¥ 13 B
Legal capital surplus	¥ 1 B	¥ 1 B	¥ 3 B	¥ 12 B	¥ 12 B
Other capital surplus	¥ 235 M	¥ 236 M	¥ 243 M	¥ 244 M	¥ 226 M
Capital surplus	¥ 1 B	¥ 1 B	¥ 4 B	¥ 12 B	¥ 12 B
Legal retained earnings	¥ 366 M	¥ 366 M	¥ 366 M	¥ 366 M	¥ 366 M
Reserve for special depreciation			¥ 342 M	¥ 285 M	¥ 281 M
General reserve	¥ 7 B	¥ 9 B	¥ 10 B	¥ 12 B	¥ 14 B
Retained earnings brought forward	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 1 B
Retained earnings	¥ 9 B	¥ 11 B	¥ 13 B	¥ 15 B	¥ 16 B
Treasury stock	¥ -255 M	¥ -423 M	¥ -392 M	¥ -1 B	¥ -1 B
Shareholders' equity	¥ 14 B	¥ 16 B	¥ 22 B	¥ 40 B	¥ 40 B
Valuation difference on available-for-sale securities	¥ 57 M	¥ 44 M	¥ -32 M	¥ -21 M	¥ 88 M
Revaluation reserve for land	¥ 264 M	¥ 263 M	¥ 261 M	¥ 261 M	¥ 297 M
Valuation and translation adjustments	¥ 321 M	¥ 308 M	¥ 229 M	¥ 239 M	¥ 385 M
Liabilities and net assets	¥ 45 B	¥ 51 B	¥ 59 B	¥ 76 B	¥ 79 B
Other	¥ 44 K	¥ 24 K	¥ 3 K
Non-operating notes receivable	¥ 479 M	¥ 482 M
Merchandise	¥ 2 B
Finished goods	¥ 5 B
Raw materials	¥ 1 B
Supplies	¥ 2 M
Provision for directors' bonuses	¥ 27 M
Non-Consolidated :Income statement (PL) Consolidated | Non-Consolidated Balance sheet | Income statement | Shareowners' equity
Non-Consolidated :Income statement (Annual )	2008-11-30	2009-11-30	2010-11-30	2011-11-30	2012-03-31	2013-03-31
Net sales	¥ 40 B	¥ 52 B	¥ 62 B	¥ 76 B	¥ 26 B
Operating income	¥ 4 B	¥ 5 B	¥ 6 B	¥ 5 B	¥ 1 B
Ordinary income	¥ 4 B	¥ 5 B	¥ 5 B	¥ 5 B	¥ 2 B
Net income	¥ 2 B	¥ 2 B	¥ 2 B	¥ 3 B	¥ 1 B
Cost of sales	¥ 22 B	¥ 30 B	¥ 37 B	¥ 48 B	¥ 17 B
Cost of purchased goods	¥ 10 B	¥ 14 B	¥ 18 B	¥ 26 B	¥ 9 B
Cost of products manufactured	¥ 14 B	¥ 16 B	¥ 18 B	¥ 25 B	¥ 8 B
Transfer to other account	¥ 74 M	¥ 285 M	¥ 138 M	¥ 286 M	¥ 10 M
Beginning merchandise and finished goods	¥ 4 B	¥ 7 B	¥ 8 B	¥ 8 B	¥ 11 B
Total	¥ 29 B	¥ 39 B	¥ 46 B	¥ 60 B	¥ 29 B
Ending merchandise and finished goods	¥ 7 B	¥ 8 B	¥ 8 B	¥ 11 B	¥ 12 B
Advertising expenses	¥ 347 M	¥ 343 M	¥ 707 M	¥ 731 M	¥ 50 M
Depreciation	¥ 302 M	¥ 453 M	¥ 649 M	¥ 1 B	¥ 485 M
Provision of allowance for doubtful accounts	¥ 160 M	¥ 1 M		¥ 85 M	¥ 15 M
Provision for bonuses				-	¥ 246 M
Retirement benefit expenses	¥ 106 M	¥ 163 M	¥ 155 M	¥ 232 M	¥ 74 M
Research and development expenses	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B	¥ 783 M
Salaries and allowances	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 839 M
Rent expenses	¥ 629 M	¥ 853 M	¥ 854 M	¥ 837 M	¥ 265 M
Promotion expenses	¥ 4 B	¥ 7 B	¥ 8 B	¥ 10 B	¥ 3 B
Traveling and transportation expenses	¥ 325 M	¥ 353 M	¥ 357 M	¥ 343 M	¥ 125 M
Other	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 935 M
Selling, general and administrative expenses	¥ 13 B	¥ 17 B	¥ 19 B	¥ 22 B	¥ 7 B
Gross profit	¥ 18 B	¥ 22 B	¥ 25 B	¥ 28 B	¥ 9 B
Gross profit-net	¥ 18 B	¥ 22 B	¥ 25 B	¥ 28 B	¥ 9 B
Provision for sales returns	¥ 1 M		¥ 9 M	¥ 12 M	-
Reversal of provision for sales returns		¥ 17 M		-	¥ 3 M
Interest income	¥ 32 M	¥ 36 M	¥ 32 M	¥ 34 M	¥ 8 M
Dividends income	¥ 9 M	¥ 12 M	¥ 13 M	¥ 20 M	¥ 61 M
Compensation income				¥ 24 M	¥ 44 M
Other	¥ 43 M	¥ 76 M	¥ 118 M	¥ 128 M	¥ 80 M
Non-operating income	¥ 87 M	¥ 237 M	¥ 272 M	¥ 282 M	¥ 252 M
Interest expenses	¥ 145 M	¥ 233 M	¥ 196 M	¥ 163 M	¥ 41 M
Stock issuance cost				¥ 100 M	-
Commission fee		¥ 86 M	¥ 121 M	¥ 33 M	¥ 14 M
Loss on sales of accounts receivable			¥ 70 M	¥ 81 M	¥ 28 M
Other	¥ 34 M	¥ 127 M	¥ 108 M	¥ 135 M	¥ 14 M
Non-operating expenses	¥ 242 M	¥ 509 M	¥ 610 M	¥ 516 M	¥ 99 M
Gain on sales of noncurrent assets	¥ 1 M	¥ 204 K	¥ 928 K	¥ 2 M	-
Extraordinary income	¥ 19 M	¥ 204 K	¥ 4 M	¥ 2 M	-
Loss on disaster				¥ 174 M	-
Loss on disposal of noncurrent assets	¥ 104 M	¥ 20 M	¥ 54 M	¥ 79 M	-
Loss on valuation of investment securities	¥ 10 M	¥ 84 M	¥ 47 M	¥ 95 M	-
Other			¥ 11 M	¥ 19 M	-
Extraordinary loss	¥ 196 M	¥ 379 M	¥ 990 M	¥ 544 M	-
Income before income taxes	¥ 4 B	¥ 4 B	¥ 4 B	¥ 5 B	¥ 2 B
Income taxes	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 900 M
Income taxes-current	¥ 1 B	¥ 2 B	¥ 1 B	¥ 2 B	¥ 413 M
Income taxes-deferred	¥ -119 M	¥ -258 M	¥ 107 M	¥ -378 M	¥ 486 M
Rent income on facilities			¥ 55 M
Loss on sales of notes payable	¥ 62 M	¥ 62 M	¥ 33 M
Reversal of allowance for doubtful accounts			¥ 3 M
Impairment loss	¥ 58 M	¥ 1 M	¥ 378 M
Loss on valuation of inventories		¥ 232 M
Provision for directors' bonuses	¥ 27 M
Reversal of provision for loss on liquidation of subsidiaries and affiliates	¥ 17 M
Non-Consolidated :Shareowners' equity (SS) Consolidated | Non-Consolidated Balance sheet | Income statement | Shareowners' equity
Non-Consolidated :Shareowners' equity (Annual )	2008-11-30	2009-11-30	2010-11-30	2011-11-30	2012-03-31
Issuance of new shares			¥ 2 B	¥ 8 B	-
Total changes of items during the period			¥ 2 B	¥ 8 B	-
Issuance of new shares			¥ 2 B	¥ 8 B	-
Total changes of items during the period			¥ 2 B	¥ 8 B	-
Disposal of treasury stock	¥ 19 M	¥ 644 K	¥ 7 M	¥ 806 K	¥ -18 M
Total changes of items during the period	¥ 148 M	¥ 644 K	¥ 7 M	¥ 806 K	¥ -18 M
Issuance of new shares			¥ 2 B	¥ 8 B	-
Disposal of treasury stock	¥ 19 M	¥ 644 K	¥ 7 M	¥ 806 K	¥ -18 M
Total changes of items during the period	¥ 148 M	¥ 644 K	¥ 2 B	¥ 8 B	¥ -18 M
Total changes of items during the period					-
Reversal of reserve for special depreciation				¥ -57 M	¥ -3 M
Total changes of items during the period			¥ 342 M	¥ -57 M	¥ -3 M
Provision of general reserve	¥ 1 B	¥ 2 B	¥ 1 B	¥ 1 B	¥ 1 B
Total changes of items during the period	¥ 1 B	¥ 2 B	¥ 1 B	¥ 1 B	¥ 1 B
Dividends from surplus	¥ -890 M	¥ -864 M	¥ -925 M	¥ -1 B	¥ -640 M
Reversal of reserve for special depreciation				¥ 57 M	¥ 3 M
Provision of general reserve	¥ -1 B	¥ -2 B	¥ -1 B	¥ -1 B	¥ -1 B
Total changes of items during the period	¥ -322 M	¥ -57 M	¥ -181 M	¥ 541 M	¥ -1 B
Dividends from surplus	¥ -890 M	¥ -864 M	¥ -925 M	¥ -1 B	¥ -640 M
Net income	¥ 2 B	¥ 2 B	¥ 2 B	¥ 3 B	¥ 1 B
Total changes of items during the period	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 548 M
Purchase of treasury stock	¥ -9 M	¥ -188 M	¥ -1 M	¥ -861 M	¥ -250 K
Disposal of treasury stock	¥ 159 M	¥ 20 M	¥ 33 M	¥ 55 M	¥ 93 M
Total changes of items during the period	¥ 213 M	¥ -168 M	¥ 31 M	¥ -805 M	¥ 93 M
Issuance of new shares			¥ 4 B	¥ 16 B	-
Dividends from surplus	¥ -890 M	¥ -864 M	¥ -925 M	¥ -1 B	¥ -640 M
Net income	¥ 2 B	¥ 2 B	¥ 2 B	¥ 3 B	¥ 1 B
Purchase of treasury stock	¥ -9 M	¥ -188 M	¥ -1 M	¥ -861 M	¥ -250 K
Disposal of treasury stock	¥ 178 M	¥ 20 M	¥ 40 M	¥ 56 M	¥ 75 M
Total changes of items during the period	¥ 1 B	¥ 1 B	¥ 6 B	¥ 17 B	¥ 623 M
Net changes of items other than shareholders' equity	¥ -190 M	¥ -12 M	¥ -76 M	¥ 10 M	¥ 110 M
Total changes of items during the period	¥ -190 M	¥ -12 M	¥ -76 M	¥ 10 M	¥ 110 M
Net changes of items other than shareholders' equity	¥ 732 M	¥ -729 K	¥ -2 M		¥ 36 M
Total changes of items during the period	¥ 732 M	¥ -729 K	¥ -2 M		¥ 36 M
Net changes of items other than shareholders' equity	¥ 541 M	¥ -13 M	¥ -79 M	¥ 10 M	¥ 146 M
Total changes of items during the period	¥ 541 M	¥ -13 M	¥ -79 M	¥ 10 M	¥ 146 M
Issuance of new shares			¥ 4 B	¥ 16 B	-
Dividends from surplus	¥ -890 M	¥ -864 M	¥ -925 M	¥ -1 B	¥ -640 M
Net income	¥ 2 B	¥ 2 B	¥ 2 B	¥ 3 B	¥ 1 B
Purchase of treasury stock	¥ -9 M	¥ -188 M	¥ -1 M	¥ -861 M	¥ -250 K
Disposal of treasury stock	¥ 178 M	¥ 20 M	¥ 40 M	¥ 56 M	¥ 75 M
Net changes of items other than shareholders' equity	¥ 541 M	¥ -13 M	¥ -79 M	¥ 10 M	¥ 146 M
Total changes of items during the period	¥ 2 B	¥ 1 B	¥ 6 B	¥ 17 B	¥ 769 M
Provision of reserve for special depreciation			¥ 342 M
Provision of reserve for special depreciation			¥ -342 M
Reversal of revaluation reserve for land	¥ -732 M	¥ 729 K	¥ 2 M
Reversal of revaluation reserve for land	¥ -732 M	¥ 729 K	¥ 2 M
Reversal of revaluation reserve for land	¥ -732 M	¥ 729 K	¥ 2 M
Reversal of revaluation reserve for land	¥ -732 M	¥ 729 K	¥ 2 M
Provision of reserve for special depreciation
Provision of general reserve
Increase by share exchanges	¥ 129 M
Increase by share exchanges	¥ 129 M
Increase by share exchanges	¥ 193 M
Increase by share exchanges	¥ 193 M

Free Download

*Free Download Financial Statement dataMember limited service.

[Data] Balance sheet, Income statement, Cash flow statement, Shareowners' equity (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: Nichi-Iko Pharmaceutical (Annual )

Statement Type

Annual : Nichi-Iko Pharmaceutical

First quarter : Nichi-Iko Pharmaceutical

Second quarter : Nichi-Iko Pharmaceutical

Third quarter : Nichi-Iko Pharmaceutical

Analysis Menu

Outline : Nichi-Iko Pharmaceutical

Statement : Nichi-Iko Pharmaceutical

Rating : Nichi-Iko Pharmaceutical

Indicator : Nichi-Iko Pharmaceutical

Download : Nichi-Iko Pharmaceutical

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Toyama - EDIUNET Prefectures

Toyama富山市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
Nichi-Iko Pharmaceutical	4541	TSE 1st	Chemicals	3	Annual	A

Related Company

KUMIAI CHEMICAL INDUSTRY (Sales ¥ 49 B)

NATOCO (Sales ¥ 16 B)

TAIYO HOLDINGS (Sales ¥ 36 B)

TOAGOSEI CO (Sales ¥ 148 B)

Nichi-Iko Pharmaceutical (Sales ¥ 93 B)

栄研化学 (Sales ¥ 28 B)

TENMA (Sales ¥ 58 B)

Noevir Holdings (Sales ¥ 46 B)

ONO PHARMACEUTICAL (Sales ¥ 145 B)

Dr.Ci:Labo (Sales ¥ 33 B)

KANEKA (Sales ¥ 476 B)

東京応化工業 (Sales ¥ 72 B)

SAWAI PHARMACEUTICAL (Sales ¥ 80 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .